📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR). (2018)

First Author: Iskandar IYK

Attributed to: MICA: Psoriasis Stratification to Optimise Relevant Therapy (PSORT) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jid.2017.09.044

PubMed Identifier: 29080680

Publication URI: http://europepmc.org/abstract/MED/29080680

Type: Journal Article/Review

Volume: 138

Parent Publication: The Journal of investigative dermatology

Issue: 4

ISSN: 0022-202X